Amyloid-β-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 187-199

  Verbeek, Marcel M ^a   Van Nostrand, William E ^b   Otte Höller, Irene ^a   Wesseling, Pieter ^a   De Waal, Robert M W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN A2; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; AMYLOIDOSIS; BIOACCUMULATION; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; CELL CULTURE; CELL DEATH; CELL DEGENERATION; CELL SURFACE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; FAMILIAL DISEASE; GENE MUTATION; GENOTYPE; HUMAN; INHERITANCE; PERICYTE; RISK; SMOOTH MUSCLE FIBER; VASCULAR AMYLOIDOSIS; VASCULAR SMOOTH MUSCLE;

EID: 0034099267     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06368.x     Document Type: Conference Paper

References (39)

1. 1. VINTERS, H.V. & J.J. GILBERT. 1983. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14: 924-928.
2. 2. GLENNER, G.G., J.H. HENRY & S. FUJIHARA. 1981. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann. Pathol. 1: 120-129.
3. 3. ELLIS, R.J., J.M. OLICHNEY, L.J. THAL, S.S. MIRRA, J.C. MORRIS, D. BEEKLY & A. HEYMAN. 1996. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part 15. Neurology 46: 1592-1596.
4. 4. VERBEEK, M.M., P. EIKELENBOOM & R.M.W. DE WAAL. 1997. Differences in the pathogenesis between senile plaques and congophilic angiopathy in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 56: 751-761.
5. 5. LORENZO, A. & B.A. YANKNER. 1994. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91: 12243-12247.
6. 6. PIKE, C.J., D. BURDICK, A.J. WALENCEWICZ, C.G. GLABE & C.W. COTMAN. 1993. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13: 1676-1687.
7. 7. DAVIS-SALINAS, J. & W.E. VAN NOSTRAND. 1995. Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270: 20887-20890.
8. 8. VERBEEK, M.M., R.M.W. DE WAAL, J.J. SCHIPPER & W.E. VAN NOSTRAND. 1997. Rapid degeneration of cultured human brain pericytes by amyloid β protein. J. Neurochem. 68: 1135-1141.
9. 9. DAVIS-SALINAS, J., S.M. SAPORITO-IRWIN, C.W. COTMAN & W.E. VAN NOSTRAND. 1995. Amyloid β-protein induces its own production in cultured degenerating cerbrovascular smooth muscle cells. J. Neurochem. 65: 931-934.
10. 10. DAVIS, J. & W.E. VAN NOSTRAND. 1996. Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc. Natl. Acad. Sci. USA 93: 2996-3000.
11. 11. CORDER, E.H., A.M. SAUNDERS, W.J. STRITTMATTER, D.E. SCHMECHEL, P.C. GASKELL, G.W. SMALL, A.D. ROSES, J.L. HAINES & M.A. PERICAK-VANCE. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
12. 12. SAUNDERS, A.M., W.J. STRITTMATTER, D. SCHMECHEL, P.H. ST. GEORGE-HYSLOP, M.A. PERICAK-VANCE, S.H. JOO, B.L. ROSI, J.F. GUSELLA, D.R. CRAPPER-MACLACHLAN, M.J. ALBERTS, C. HULETTE, B. CRAIN, D. GOLDGABER & A.D. ROSES. 1993. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
13. 13. HENDERSON, A.S., S. EASTEAL, A.F. JORM, A.J. MACKINNON, A.E. KORTEN, H. CHRISTENSEN, L. CROFT & P.A. JACOMB. 1995. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 346: 1387-1390.
14. 14. CORDER, E.H., A.M. SAUNDERS, N.J. RISCH, W.J. STRITTMATTER, D.E. SCHMECHEL, J.P.C. GASKELL, J.B. RIMMLER, P.A. LOCKE, P.M. CONNEALLY, K.E. SCHMADER, G.W. SMALL, A.D. ROSES, J.L. HAINES & M.A. PERICAK-VANCE. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7: 180-183.
15. 15. GREENBERG, S.M., M.E. BRIGGS, B.T. HYMAN, G.J. KOKORIS, C. TAKIS, D.S. KANTER, C.S. KASE & M.S. PESSIN. 1996. Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27: 1333-1337.
16. 16. PREMKUMAR, D.R.D., D.L. COHEN, P. HEDERA, R.P. FRIEDLAND & R.N. KALARIA. 1996. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148: 2083-2095.
17. 17. NICOLL, J.A.R., C. BURNETT, S. LOVE, D.I. GRAHAM, J.W. IRONSIDE & H.V. VINTERS. 1996. High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann. Neurol. 39: 682.
18. 18. SCHMECHEL, D.E., A.M. SAUNDERS, W.J. STRITTMATTER, B.J. CRAIN, C.M. HULETTE, S.H. JOO, M.A. PERICAK-VANCE, D. GOLDGABER & A.D. ROSES. 1993. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 9649-9653.
19. 19. VERBEEK, M.M., I. OTTE-HÖLLER, R. VEERHUIS, D.J. RUITER & R.M.W. DE WAAL. 1998. Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer's disease. Acta Neuropathol. 96: 628-636.
20. 20. NAMBA, Y., M. TOMONAGA, H. KAWASAKI, E. OTOMO & K. IKEDA. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res. 541: 163-166.
21. 21. YAMAGUCHI, H., K. ISHIGURO, S. SUGIHARA, Y. NAKAZATO, T. KAWARABAYASHI, X. SUN & S. HIRAI. 1994. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol. 88: 413-419.
22. 22. STRITTMATTER, W.J., K.H. WEISGRABER, D.Y. HUANG, L.-M. DONG, G.S. SALVESEN, M. PERICAK-VANCE, D. SCHMECHEL, A.M. SAUNDERS, D. GOLDGABER & A.D. ROSES. 1993. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102.
23. 23. SANAN, D.A., K.H. WEISGRABER, S.J. RUSSELL, R.W. MAHLEY, D. HUANG, A. SAUNDERS, D. SCHEMEL, T. WISNIEWSKI, B. FRANGIONE, A.D. ROSES & W.J. STRITTMATTER. 1994. Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94: 860-869.
24. 24. WISNIEWSKI, T., E.M. CASTAÑO, A. GOLABEK, T. VOGEL & B. FRANGIONE. 1994. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145: 1030-1035.
25. 25. BALES, K.R., T. VERINA, R.C. DODEL, Y. Du, L. ALTSTIEL, M. BENDER, P. HYSLOP, E.M. JOHNSTONE, S.P. LITTLE, D.J. CUMMINS, P. PICCARDO, B. GHETTI & S.M. PAUL. 1997. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition [letter] [see comments]. Nat. Genet. 17: 263-264.
26. 26. VERBEEK, M.M., I. OTTE-HÖLLER, P. WESSELING, D.J. RUITER & R.M.W. DE WAAL. 1994. Induction of α-smooth muscle actin expression in cultured human brain pericytes by TGFβ1. Am. J. Pathol. 144: 372-382.
27. 27. VERBEEK, M.M., J.R. WESTPHAL, D.J. RUITER & R.M.W. DE WAAL. 1995. T lymphocyte adhesion to human brain pericytes is mediated via VLA-4/VCAM-1 interactions. J. Immunol. 154: 5876-5884.
28. 28. HIXSON, J.E. & D.T. VERNIER. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
29. 29. WENHAM, P.R., W.H. PRICE & G. BLANDELL. 1991. Apolipoprotein E genotyping by one-stage PCR [letter]. Lancet 337: 1158-1159.
30. 30. WISNIEWSKI, H.M., J. WEGIEL, K.C. WANG & B. LACH. 1992. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol. 84: 117-127.
31. 31. KIMURA, T., T. HASHIMURA & T. MIYAKAWA. 1991. Observations of microvessels in the brain with Alzheimer's disease by the scanning electron microscope. Jpn. J. Psychiatr. Neurol. 45: 671-676.
32. 32. KAWAI, M., R.N. KALARIA, P. CRAS, S.L. SIEDLAK, M.E. VELASCO, E.R. SHELTON, H.W. CHAN, B. GREENBERG & G. PERRY. 1993. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res. 623: 142-146.
33. 33. PERRY, G., M.A. SMITH, C.E. MCCANN, S.L. SIEDLAK, P.K. JONES & R.P. FRIEDLAND. 1998. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Res. 791: 63-66.
34. 34. GREENBERG, S.M., J.P. VONSATTEL, A.Z. SEGAL, R.I. CHIU, A.E. CLATWORTHY, A. LIAO, B.T. HYMAN & G.W. REBECK. 1998. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 50: 961-965.
35. 35. LUYENDIJK, W., G.T.A.M. BOTS, M. VEGTER-VAN DER VLIS, L.N. WENT & B. FRANGIONE. 1988. Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy. J. Neurol. Sci. 85: 267-280.
36. 36. MA, J., A. YEE, H.B. BREWER, JR., S. DAS & H. POTTER. 1994. Amyloid associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372: 92-94.
37. 37. LADU, M.J., M.T. FALDUTO, A.M. MANELLI, C.A. REARDON, G.S. GETZ & D.E. FRAIL. 1994. Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269: 23403-23406.
38. 38. ALESHKOV, S., C.R. ABRAHAM & V.I. ZANNIS. 1997. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Biochemistry 36: 10571-10580.
39. 39. VAN NOSTRAND, WE., J.P. MELCHOR & L. RUFFINI. 1998. Pathologic amyloid β-protein cell surface assembly on cultured human cerebrovascular smooth muscle cells. J. Neurochem. 70: 216-223.